Skip to main content

Table 1 Clinical Characteristics for Total Study Group

From: Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration

 

Group A (n = 24)

Group B (n = 18)

Control Group (n = 19)

Age (years)

56 ± 11

61 ± 13

59 ± 12

Male gender

14(58%)

10(56%)

10(57%)

Smokers

15(62.5%)

11(62%)

11(62.5%)

Systolic Blood Pressure (mmHg)

145 ± 20

143 ± 22

139 ± 25

Diastolic Blood Pressure (mmHg)

80 ± 10

82 ± 11

80 ± 11

Known hypertension (160/90 mmHg)

8 (33.4%)

6 (34%)

7(35%)

Lone AF

11(45.8%)

8 (44.2%)

-

Coronary artery Disease

5(20.8%)

4(22%)

5(22.8%)

Diabetes mellitus

6(25%)

4(22%)

4(22.3%)

Hct(%)

45.8 ± 3.9

44.9 ± 4.2

45 ± 3.6

Hb(g/dl)

15.3 ± 1.34

14.8 ± 2.9

15.2 ± 3.1

Fbg (mg/dl)

229.9 ± 27.0

237 ± 37.6

227 ± 26

P value: non significant (NS)

Echocardiographic data for Both Groups pre cardioversion

  

Group A

Group B

Left atrial diameter(cm)

 

4.2 ± 0.6

4.0 ± 0.8

Left ventricular diastolic dimension (cm)

 

5.2 ± 1.0

5.0 ± 0.9

Left ventricular systolic dimension (cm)

 

4.1 ± 0.5

4.0 ± 0.8

  1. P value: non significant (NS)